Extracellular Vesicles in Prostate Cancer: New Future Clinical Strategies?

Prostate cancer (PCa) is the most common cancer—excluding skin tumors—in men older than 50 years of age. Over time, the ability to diagnose PCa has improved considerably, mainly due to the introduction of prostate-specific antigen (PSA) in the clinical routine. However, it is important to take into...

Descripción completa

Detalles Bibliográficos
Autores principales: Giusti, Ilaria, Dolo, Vincenza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950949/
https://www.ncbi.nlm.nih.gov/pubmed/24707491
http://dx.doi.org/10.1155/2014/561571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950949/
https://www.ncbi.nlm.nih.gov/pubmed/24707491
http://dx.doi.org/10.1155/2014/561571

Ejemplares similares